A Busy Week for Multiple Sclerosis News

It was good news for Novartis and bad news for Merck KGaA this week as regulators handed down their decisions on each company’s multiple sclerosis (MS) drug candidate.

Read more »

No Shortage of Hopefuls in the Multibillion-Dollar Blood Thinner Business

Patients hoping for a new alternative to the blockbuster blood thinner Plavix will have to wait a bit longer for a verdict on a promising candidate.

Read more »

New National Drug Abuse Strategy Emphasizes Prevention

On May 11, the Obama administration unveiled its 2010 National Drug Control Strategy to reduce illicit drug use in America.

Read more »

Making Diabetes Less Painful to Deal With

Diabetes patients don’t always engage in the self-care needed to control the disease.

Read more »

Echo Therapeutics: Positive Developments for Needle-Free Monitoring System

On 11/19/09, the Company announced positive results in a pilot clinical study which included Prelude skin preparation and the placement of 10 Symphony tCGM biosensors on subjects with Type 1 or Type 2 Diabetes.

Read more »

Onyx Pharmaceuticals to Acquire Proteolix

Onyx Pharmaceuticals has agreed to purchase private biotechnology company Proteolix for $276 million in cash.

Read more »

New Developments in Detecting and Treating Alzheimer’s

Every 70 seconds, someone develops Alzheimer’s disease. This startling figure from the Alzheimer’s Association underlines the desperate need for new tools to diagnose and treat this debilitating illness.

Read more »